Search results
Moderna, Carvana and Peloton rise premarket; DoorDash, Fastly, Zillow fall By Investing.com
Investing.com· 1 day agoModerna, Carvana and Peloton rise premarket; DoorDash, Fastly, Zillow fall
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 3 days agoWe've identified 1 warning sign for Moderna that investors should be aware of in a dynamic business...
Earnings call: Moderna reports a net loss of $12.2 billion By Investing.com
Investing.com· 17 hours agoModerna , Inc. (NASDAQ:MRNA) reported a mixed first quarter in 2024, with significant business...
Stock Market Crash Warning: Don't Get Caught Holding These 3 Cathie Wood Stocks
InvestorPlace· 1 day agoFor a time, Cathie Wood was the hottest investor on Wall Street. Ark Invest was bringing in billions of dollars in new assets under management. A February report found that in aggregate, her ...
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks via Yahoo Finance· 3 days agoThe final step today is to look at a stock that meets our ESP qualifications. Moderna (MRNA) earns a...
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant portion of his...
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks· 3 days agoInvestors can't control the latter, but they can focus on a company's earnings results every quarter. This means that investors might want to take advantage of these earnings surprises. Now ...
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
InvestorPlace· 3 days agoBiotech stocks offer the opportunity to invest in life-saving treatments and drugs. If you want to...
Midday movers: Carvana and Qualcomm rise; DoorDash, Fastly, Zillow fall By Investing.com
Investing.com· 1 day agoMidday movers: Carvana and Qualcomm rise; DoorDash, Fastly, Zillow fall
Moderna: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 1 day agoResearch was for a loss of $3.59 per share. The biotechnology company posted revenue of $167 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $124.7 ...
